Self-Directed Hand Therapy for Stroke Recovery
(SAGEH Trial)
Trial Summary
What is the purpose of this trial?
This study aims at comparing manual function outcomes between the standard of care and additional self-administered hand therapy after stroke. Strokes are common neurological injuries, and although rates of survival have increased in recent decades, survivors often continue to experience deficiencies in hand dexterity and bimanual function. Most motor recovery takes place within the first 3 months after a stroke. This initial period is necessary for stabilizing the patient but also provides different opportunities to foster motor recovery. Functional gains, including instances after the post-acute period, have been observed after regular and frequent (high dosage) therapy, suggesting that recovery is likely influenced by practice-driven sensorimotor learning. These findings motivate the implementation of daily therapeutic regimes beyond post-stroke hospitalization and basic motor function, aiming instead at addressing overlooked deficiencies in manipulation and bimanual coordination. While some hand therapy is often provided during outpatient therapy visits (the standard of care), self-administered sessions play a large role in implementing additional daily therapy. As a result, the investigators are interested in both the implementation of self-administered regimes and measuring clinical outcomes with and without self-administered therapy.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Self-Administered Gaming and Exercise at Home (SAGEH) for stroke recovery?
Research shows that using commercial gaming devices for stroke rehabilitation can improve arm movement and function. A study found that stroke survivors using a virtual-reality gaming system reported improvements in arm use and enjoyed the therapy, suggesting that gaming can be an effective and enjoyable way to aid recovery.12345
Is self-directed hand therapy for stroke recovery safe for humans?
Research on self-directed exergaming for stroke recovery shows that it can safely increase exercise duration and repetitions without additional professional supervision. However, concerns about safety and usability for independent home use remain largely unaddressed, indicating a need for further research.16789
How does the Self-Administered Gaming and Exercise at Home (SAGEH) treatment differ from other stroke recovery treatments?
The SAGEH treatment is unique because it allows stroke patients to perform hand therapy at home using gaming technology, which is designed to be engaging and motivating. This approach combines exercise with interactive games, making it different from traditional therapies that may not incorporate such technology or the motivational aspect of gaming.135710
Research Team
Steven R Zeiler, MD, PhD
Principal Investigator
Johns Hopkins University
Eligibility Criteria
The SAGEH trial is for adults over 21 who've had a stroke within the last 6 weeks, resulting in hand weakness but can still do some exercises. They must be able to communicate in English and give consent. People with severe arm impairment, recent Botox treatments, other major health issues affecting motor function or cognitive impairments are not eligible.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline gaming, functional, and cognitive assessments while still inpatients
Treatment
Participants receive self-administered therapy sessions with telemedicine check-ins over 3 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Self-Administered Gaming and Exercise at Home (SAGEH)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Sheikh Khalifa Stroke Institute
Collaborator